UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of March 2022
Commission
File Number 001-38208
Dragon
Victory International Limited
Suite
1508, Central Plaza
18
Harbour Road, Wan Chai, Hong Kong
China
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXPLANATORY
NOTE
Dragon
Victory International Limited (the “Company”) is furnishing this report on Form 6-K to provide the six-month interim financial
statements for the period ended September 30, 2021 and incorporate such financial statements into the Company’s registration statements
referenced below.
This
Form 6-K is hereby incorporated by reference into the registration statements of the Company on Form F-3 (Registration Number
333-261898), Form F-3 (Registration Number 333-252688), Form F-3 (Registration Number 333-251297), and on Form S-8 (Registration
Number 333-255251), as amended, and into each prospectus outstanding under the foregoing registration statements, to the extent not
superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or
the Securities Exchange Act of 1934, as amended.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
Dragon Victory International Limited |
Date: March 11, 2022 |
|
|
By: |
/s/
Limin Liu |
|
|
Name: |
Limin Liu |
|
|
Title: |
Chief Executive Officer |
EXHIBIT
INDEX
3
false
--03-31
Q2
2021-09-30
0001682241